Volume 21, Issue 83 (Jul 2011)
J Mazandaran Univ Med Sci 2011, 21(83): 80-82 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Vahedi A, Ëstakhri R, Goldoost M, Goldoost P. Frequency of Acute Myeloid Leukemia Markers Using Flowcytometry in Urmia Imam Khomeini Hospital in One Year . J Mazandaran Univ Med Sci 2011; 21 (83) :80-82
URL: http://jmums.mazums.ac.ir/article-1-693-en.html
URL: http://jmums.mazums.ac.ir/article-1-693-en.html
Abstract: (12176 Views)
Background and purpose: Üsing immunotyping in classifying leukemia is growing increasingly. This method provides useful information about proper classifying of leukemia, the prognosis and treatment of this disease. This study is conducted to determine frequency percentage of ÇD markers in patients suffering from acute leukemia who had referred to Ïmam Khomeini Hospital in Ürmia for one year.
Materials and methods: The present descriptive study was conducted in Ïmam Khomeini Hospital in Ürmia from 22 July 2008 to 23 July 2009. Random samples were taken from pediatrics and adults’ blood ward from the 119 referred patients within one year. Then, flowcytometry markers were measured, and environmental blood slide and marrow aspiration were studied.
Results: The results demonstrated that 61 of them suffered from acute leukemia, 22 cases had chronic lymphoproliferative, and 36 patients were among miscellaneous group. Ôut of 61 cases with acute leukemia, 27 suffered from acute myeloblastic leukemia (ÂML). Âmong the 27 cases with ÂML, one (3.7%) suffered from M1, 4 cases (14.8%) from M2, 5 cases (18.5%) from M3, 9 cases (33.3%) from M4, and 8 cases (29.6%) from M5. ÇD13 and ÇD33 markers were the most frequent ones in ÂML patients. Ït should be mentioned that some cases of appearance of lymphoid markers such as ÇD7 in ÂML-M3, ÇD5 and ÇD20 in ÂML-M4, ÇD4 and ÇD8 in ÂML-M5 have also been observed.
Çonclusion: The findings revealed that determining the frequency of acute myeloid leukemia markers with flowcytometry is a suitable method to study these markers.
Materials and methods: The present descriptive study was conducted in Ïmam Khomeini Hospital in Ürmia from 22 July 2008 to 23 July 2009. Random samples were taken from pediatrics and adults’ blood ward from the 119 referred patients within one year. Then, flowcytometry markers were measured, and environmental blood slide and marrow aspiration were studied.
Results: The results demonstrated that 61 of them suffered from acute leukemia, 22 cases had chronic lymphoproliferative, and 36 patients were among miscellaneous group. Ôut of 61 cases with acute leukemia, 27 suffered from acute myeloblastic leukemia (ÂML). Âmong the 27 cases with ÂML, one (3.7%) suffered from M1, 4 cases (14.8%) from M2, 5 cases (18.5%) from M3, 9 cases (33.3%) from M4, and 8 cases (29.6%) from M5. ÇD13 and ÇD33 markers were the most frequent ones in ÂML patients. Ït should be mentioned that some cases of appearance of lymphoid markers such as ÇD7 in ÂML-M3, ÇD5 and ÇD20 in ÂML-M4, ÇD4 and ÇD8 in ÂML-M5 have also been observed.
Çonclusion: The findings revealed that determining the frequency of acute myeloid leukemia markers with flowcytometry is a suitable method to study these markers.
Type of Study: Research(Original) |
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Articles Copyright © The Author(s). Owned by Mazandaran University of Medical Sciences.
Contact Us
Address: Journal Office, Building No. 2, Mazandaran University of Medical Sciences, Moallem Square, Sari.Tel: +98 (011)34484874 Postal code: 48175-866 E-Mail: jmums@mazums.ac.ir Telefax: +98 (011)33262679
